Christian Richard's most recent trade in Cypherpunk Technologies Inc. was a trade of 75,000 Restricted Stock Units done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 94,050 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 94,050 | 168,750 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Christian Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 74,700 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 74,700 | 74,700 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 74,700 | 74,700 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |